Global Aortic and Peripheral Vascular Interventional Devices Market Outlook, In‑Depth Analysis & Forecast to 2031

1 Study Coverage
1.1 Introduction to Aortic and Peripheral Vascular Interventional Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Aortic and Peripheral Vascular Interventional Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Aorta
1.2.3 Peripheral Blood Vessels
1.2.4 Coronary Blood Vessels
1.2.5 Cerebral Blood Vessels
1.3 Market Segmentation by Application
1.3.1 Global Aortic and Peripheral Vascular Interventional Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Aortic and Peripheral Vascular Interventional Devices Revenue Estimates and Forecasts 2020-2031
2.2 Global Aortic and Peripheral Vascular Interventional Devices Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Aortic and Peripheral Vascular Interventional Devices Sales Estimates and Forecasts 2020-2031
2.4 Global Aortic and Peripheral Vascular Interventional Devices Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Aortic and Peripheral Vascular Interventional Devices Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Aortic and Peripheral Vascular Interventional Devices Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Aorta Market Size by Manufacturers
3.5.2 Peripheral Blood Vessels Market Size by Manufacturers
3.5.3 Coronary Blood Vessels Market Size by Manufacturers
3.5.4 Cerebral Blood Vessels Market Size by Manufacturers
3.6 Global Aortic and Peripheral Vascular Interventional Devices Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Aortic and Peripheral Vascular Interventional Devices Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Aortic and Peripheral Vascular Interventional Devices Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Aortic and Peripheral Vascular Interventional Devices Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Aortic and Peripheral Vascular Interventional Devices Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Aortic and Peripheral Vascular Interventional Devices Sales and Revenue by Type (2020-2031)
6.4 North America Aortic and Peripheral Vascular Interventional Devices Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Aortic and Peripheral Vascular Interventional Devices Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Aortic and Peripheral Vascular Interventional Devices Sales and Revenue by Type (2020-2031)
7.4 Europe Aortic and Peripheral Vascular Interventional Devices Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Aortic and Peripheral Vascular Interventional Devices Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Aortic and Peripheral Vascular Interventional Devices Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Aortic and Peripheral Vascular Interventional Devices Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Aortic and Peripheral Vascular Interventional Devices Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Aortic and Peripheral Vascular Interventional Devices Sales and Revenue by Type (2020-2031)
9.4 Central and South America Aortic and Peripheral Vascular Interventional Devices Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Aortic and Peripheral Vascular Interventional Devices Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Aortic and Peripheral Vascular Interventional Devices Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Aortic and Peripheral Vascular Interventional Devices Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Aortic and Peripheral Vascular Interventional Devices Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Boston Scientific
11.1.1 Boston Scientific Corporation Information
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific Aortic and Peripheral Vascular Interventional Devices Product Models, Descriptions and Specifications
11.1.4 Boston Scientific Aortic and Peripheral Vascular Interventional Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Boston Scientific Aortic and Peripheral Vascular Interventional Devices Sales by Product in 2024
11.1.6 Boston Scientific Aortic and Peripheral Vascular Interventional Devices Sales by Application in 2024
11.1.7 Boston Scientific Aortic and Peripheral Vascular Interventional Devices Sales by Geographic Area in 2024
11.1.8 Boston Scientific Aortic and Peripheral Vascular Interventional Devices SWOT Analysis
11.1.9 Boston Scientific Recent Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Business Overview
11.2.3 Abbott Aortic and Peripheral Vascular Interventional Devices Product Models, Descriptions and Specifications
11.2.4 Abbott Aortic and Peripheral Vascular Interventional Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Abbott Aortic and Peripheral Vascular Interventional Devices Sales by Product in 2024
11.2.6 Abbott Aortic and Peripheral Vascular Interventional Devices Sales by Application in 2024
11.2.7 Abbott Aortic and Peripheral Vascular Interventional Devices Sales by Geographic Area in 2024
11.2.8 Abbott Aortic and Peripheral Vascular Interventional Devices SWOT Analysis
11.2.9 Abbott Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Aortic and Peripheral Vascular Interventional Devices Product Models, Descriptions and Specifications
11.3.4 Medtronic Aortic and Peripheral Vascular Interventional Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Medtronic Aortic and Peripheral Vascular Interventional Devices Sales by Product in 2024
11.3.6 Medtronic Aortic and Peripheral Vascular Interventional Devices Sales by Application in 2024
11.3.7 Medtronic Aortic and Peripheral Vascular Interventional Devices Sales by Geographic Area in 2024
11.3.8 Medtronic Aortic and Peripheral Vascular Interventional Devices SWOT Analysis
11.3.9 Medtronic Recent Developments
11.4 Terumo
11.4.1 Terumo Corporation Information
11.4.2 Terumo Business Overview
11.4.3 Terumo Aortic and Peripheral Vascular Interventional Devices Product Models, Descriptions and Specifications
11.4.4 Terumo Aortic and Peripheral Vascular Interventional Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Terumo Aortic and Peripheral Vascular Interventional Devices Sales by Product in 2024
11.4.6 Terumo Aortic and Peripheral Vascular Interventional Devices Sales by Application in 2024
11.4.7 Terumo Aortic and Peripheral Vascular Interventional Devices Sales by Geographic Area in 2024
11.4.8 Terumo Aortic and Peripheral Vascular Interventional Devices SWOT Analysis
11.4.9 Terumo Recent Developments
11.5 Nipro
11.5.1 Nipro Corporation Information
11.5.2 Nipro Business Overview
11.5.3 Nipro Aortic and Peripheral Vascular Interventional Devices Product Models, Descriptions and Specifications
11.5.4 Nipro Aortic and Peripheral Vascular Interventional Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Nipro Aortic and Peripheral Vascular Interventional Devices Sales by Product in 2024
11.5.6 Nipro Aortic and Peripheral Vascular Interventional Devices Sales by Application in 2024
11.5.7 Nipro Aortic and Peripheral Vascular Interventional Devices Sales by Geographic Area in 2024
11.5.8 Nipro Aortic and Peripheral Vascular Interventional Devices SWOT Analysis
11.5.9 Nipro Recent Developments
11.6 B. Braun
11.6.1 B. Braun Corporation Information
11.6.2 B. Braun Business Overview
11.6.3 B. Braun Aortic and Peripheral Vascular Interventional Devices Product Models, Descriptions and Specifications
11.6.4 B. Braun Aortic and Peripheral Vascular Interventional Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 B. Braun Recent Developments
11.7 Cook Medical
11.7.1 Cook Medical Corporation Information
11.7.2 Cook Medical Business Overview
11.7.3 Cook Medical Aortic and Peripheral Vascular Interventional Devices Product Models, Descriptions and Specifications
11.7.4 Cook Medical Aortic and Peripheral Vascular Interventional Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Cook Medical Recent Developments
11.8 MicroPort
11.8.1 MicroPort Corporation Information
11.8.2 MicroPort Business Overview
11.8.3 MicroPort Aortic and Peripheral Vascular Interventional Devices Product Models, Descriptions and Specifications
11.8.4 MicroPort Aortic and Peripheral Vascular Interventional Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 MicroPort Recent Developments
11.9 Lepu Medical
11.9.1 Lepu Medical Corporation Information
11.9.2 Lepu Medical Business Overview
11.9.3 Lepu Medical Aortic and Peripheral Vascular Interventional Devices Product Models, Descriptions and Specifications
11.9.4 Lepu Medical Aortic and Peripheral Vascular Interventional Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Lepu Medical Recent Developments
11.10 Jiwei Medical
11.10.1 Jiwei Medical Corporation Information
11.10.2 Jiwei Medical Business Overview
11.10.3 Jiwei Medical Aortic and Peripheral Vascular Interventional Devices Product Models, Descriptions and Specifications
11.10.4 Jiwei Medical Aortic and Peripheral Vascular Interventional Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Jiwei Medical Recent Developments
11.11 Asahi Intecc
11.11.1 Asahi Intecc Corporation Information
11.11.2 Asahi Intecc Business Overview
11.11.3 Asahi Intecc Aortic and Peripheral Vascular Interventional Devices Product Models, Descriptions and Specifications
11.11.4 Asahi Intecc Aortic and Peripheral Vascular Interventional Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Asahi Intecc Recent Developments
11.12 Kaneka
11.12.1 Kaneka Corporation Information
11.12.2 Kaneka Business Overview
11.12.3 Kaneka Aortic and Peripheral Vascular Interventional Devices Product Models, Descriptions and Specifications
11.12.4 Kaneka Aortic and Peripheral Vascular Interventional Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Kaneka Recent Developments
11.13 Sino Medical
11.13.1 Sino Medical Corporation Information
11.13.2 Sino Medical Business Overview
11.13.3 Sino Medical Aortic and Peripheral Vascular Interventional Devices Product Models, Descriptions and Specifications
11.13.4 Sino Medical Aortic and Peripheral Vascular Interventional Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Sino Medical Recent Developments
11.14 LifeTech
11.14.1 LifeTech Corporation Information
11.14.2 LifeTech Business Overview
11.14.3 LifeTech Aortic and Peripheral Vascular Interventional Devices Product Models, Descriptions and Specifications
11.14.4 LifeTech Aortic and Peripheral Vascular Interventional Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 LifeTech Recent Developments
11.15 Gore
11.15.1 Gore Corporation Information
11.15.2 Gore Business Overview
11.15.3 Gore Aortic and Peripheral Vascular Interventional Devices Product Models, Descriptions and Specifications
11.15.4 Gore Aortic and Peripheral Vascular Interventional Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Gore Recent Developments
11.16 Cordis
11.16.1 Cordis Corporation Information
11.16.2 Cordis Business Overview
11.16.3 Cordis Aortic and Peripheral Vascular Interventional Devices Product Models, Descriptions and Specifications
11.16.4 Cordis Aortic and Peripheral Vascular Interventional Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Cordis Recent Developments
11.17 Acotec Scientific Holdings
11.17.1 Acotec Scientific Holdings Corporation Information
11.17.2 Acotec Scientific Holdings Business Overview
11.17.3 Acotec Scientific Holdings Aortic and Peripheral Vascular Interventional Devices Product Models, Descriptions and Specifications
11.17.4 Acotec Scientific Holdings Aortic and Peripheral Vascular Interventional Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Acotec Scientific Holdings Recent Developments
11.18 Zylox-Tonbridge Medical Technology
11.18.1 Zylox-Tonbridge Medical Technology Corporation Information
11.18.2 Zylox-Tonbridge Medical Technology Business Overview
11.18.3 Zylox-Tonbridge Medical Technology Aortic and Peripheral Vascular Interventional Devices Product Models, Descriptions and Specifications
11.18.4 Zylox-Tonbridge Medical Technology Aortic and Peripheral Vascular Interventional Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Zylox-Tonbridge Medical Technology Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Aortic and Peripheral Vascular Interventional Devices Industry Chain
12.2 Aortic and Peripheral Vascular Interventional Devices Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Aortic and Peripheral Vascular Interventional Devices Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Aortic and Peripheral Vascular Interventional Devices Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Aortic and Peripheral Vascular Interventional Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Aortic and Peripheral Vascular Interventional Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

List of Tables
Table 1. Global Aortic and Peripheral Vascular Interventional Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Aortic and Peripheral Vascular Interventional Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Aortic and Peripheral Vascular Interventional Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Aortic and Peripheral Vascular Interventional Devices Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Aortic and Peripheral Vascular Interventional Devices Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Aortic and Peripheral Vascular Interventional Devices Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Aortic and Peripheral Vascular Interventional Devices Sales by Region (2020-2025) & (K Units)
Table 8. Global Aortic and Peripheral Vascular Interventional Devices Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Aortic and Peripheral Vascular Interventional Devices Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Aortic and Peripheral Vascular Interventional Devices Sales Share by Manufacturers (2020-2025)
Table 12. Global Aortic and Peripheral Vascular Interventional Devices Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Aortic and Peripheral Vascular Interventional Devices Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Aortic and Peripheral Vascular Interventional Devices by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aortic and Peripheral Vascular Interventional Devices as of 2024)
Table 16. Global Aortic and Peripheral Vascular Interventional Devices Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Aortic and Peripheral Vascular Interventional Devices Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Aortic and Peripheral Vascular Interventional Devices Manufacturing Base and Headquarters
Table 19. Global Aortic and Peripheral Vascular Interventional Devices Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Aortic and Peripheral Vascular Interventional Devices Sales by Type (2020-2025) & (K Units)
Table 23. Global Aortic and Peripheral Vascular Interventional Devices Sales by Type (2026-2031) & (K Units)
Table 24. Global Aortic and Peripheral Vascular Interventional Devices Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Aortic and Peripheral Vascular Interventional Devices Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Aortic and Peripheral Vascular Interventional Devices ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Aortic and Peripheral Vascular Interventional Devices Sales by Application (2020-2025) & (K Units)
Table 29. Global Aortic and Peripheral Vascular Interventional Devices Sales by Application (2026-2031) & (K Units)
Table 30. Aortic and Peripheral Vascular Interventional Devices High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Aortic and Peripheral Vascular Interventional Devices Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Aortic and Peripheral Vascular Interventional Devices Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Aortic and Peripheral Vascular Interventional Devices ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Aortic and Peripheral Vascular Interventional Devices Growth Accelerators and Market Barriers
Table 37. North America Aortic and Peripheral Vascular Interventional Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Aortic and Peripheral Vascular Interventional Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Aortic and Peripheral Vascular Interventional Devices Growth Accelerators and Market Barriers
Table 40. Europe Aortic and Peripheral Vascular Interventional Devices Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Aortic and Peripheral Vascular Interventional Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Aortic and Peripheral Vascular Interventional Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Aortic and Peripheral Vascular Interventional Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Aortic and Peripheral Vascular Interventional Devices Growth Accelerators and Market Barriers
Table 45. Southeast Asia Aortic and Peripheral Vascular Interventional Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Aortic and Peripheral Vascular Interventional Devices Investment Opportunities and Key Challenges
Table 47. Central and South America Aortic and Peripheral Vascular Interventional Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Aortic and Peripheral Vascular Interventional Devices Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Aortic and Peripheral Vascular Interventional Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Boston Scientific Corporation Information
Table 51. Boston Scientific Description and Major Businesses
Table 52. Boston Scientific Product Models, Descriptions and Specifications
Table 53. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Boston Scientific Sales Value Proportion by Product in 2024
Table 55. Boston Scientific Sales Value Proportion by Application in 2024
Table 56. Boston Scientific Sales Value Proportion by Geographic Area in 2024
Table 57. Boston Scientific Aortic and Peripheral Vascular Interventional Devices SWOT Analysis
Table 58. Boston Scientific Recent Developments
Table 59. Abbott Corporation Information
Table 60. Abbott Description and Major Businesses
Table 61. Abbott Product Models, Descriptions and Specifications
Table 62. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Abbott Sales Value Proportion by Product in 2024
Table 64. Abbott Sales Value Proportion by Application in 2024
Table 65. Abbott Sales Value Proportion by Geographic Area in 2024
Table 66. Abbott Aortic and Peripheral Vascular Interventional Devices SWOT Analysis
Table 67. Abbott Recent Developments
Table 68. Medtronic Corporation Information
Table 69. Medtronic Description and Major Businesses
Table 70. Medtronic Product Models, Descriptions and Specifications
Table 71. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Medtronic Sales Value Proportion by Product in 2024
Table 73. Medtronic Sales Value Proportion by Application in 2024
Table 74. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 75. Medtronic Aortic and Peripheral Vascular Interventional Devices SWOT Analysis
Table 76. Medtronic Recent Developments
Table 77. Terumo Corporation Information
Table 78. Terumo Description and Major Businesses
Table 79. Terumo Product Models, Descriptions and Specifications
Table 80. Terumo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Terumo Sales Value Proportion by Product in 2024
Table 82. Terumo Sales Value Proportion by Application in 2024
Table 83. Terumo Sales Value Proportion by Geographic Area in 2024
Table 84. Terumo Aortic and Peripheral Vascular Interventional Devices SWOT Analysis
Table 85. Terumo Recent Developments
Table 86. Nipro Corporation Information
Table 87. Nipro Description and Major Businesses
Table 88. Nipro Product Models, Descriptions and Specifications
Table 89. Nipro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Nipro Sales Value Proportion by Product in 2024
Table 91. Nipro Sales Value Proportion by Application in 2024
Table 92. Nipro Sales Value Proportion by Geographic Area in 2024
Table 93. Nipro Aortic and Peripheral Vascular Interventional Devices SWOT Analysis
Table 94. Nipro Recent Developments
Table 95. B. Braun Corporation Information
Table 96. B. Braun Description and Major Businesses
Table 97. B. Braun Product Models, Descriptions and Specifications
Table 98. B. Braun Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. B. Braun Recent Developments
Table 100. Cook Medical Corporation Information
Table 101. Cook Medical Description and Major Businesses
Table 102. Cook Medical Product Models, Descriptions and Specifications
Table 103. Cook Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Cook Medical Recent Developments
Table 105. MicroPort Corporation Information
Table 106. MicroPort Description and Major Businesses
Table 107. MicroPort Product Models, Descriptions and Specifications
Table 108. MicroPort Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. MicroPort Recent Developments
Table 110. Lepu Medical Corporation Information
Table 111. Lepu Medical Description and Major Businesses
Table 112. Lepu Medical Product Models, Descriptions and Specifications
Table 113. Lepu Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Lepu Medical Recent Developments
Table 115. Jiwei Medical Corporation Information
Table 116. Jiwei Medical Description and Major Businesses
Table 117. Jiwei Medical Product Models, Descriptions and Specifications
Table 118. Jiwei Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Jiwei Medical Recent Developments
Table 120. Asahi Intecc Corporation Information
Table 121. Asahi Intecc Description and Major Businesses
Table 122. Asahi Intecc Product Models, Descriptions and Specifications
Table 123. Asahi Intecc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Asahi Intecc Recent Developments
Table 125. Kaneka Corporation Information
Table 126. Kaneka Description and Major Businesses
Table 127. Kaneka Product Models, Descriptions and Specifications
Table 128. Kaneka Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Kaneka Recent Developments
Table 130. Sino Medical Corporation Information
Table 131. Sino Medical Description and Major Businesses
Table 132. Sino Medical Product Models, Descriptions and Specifications
Table 133. Sino Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Sino Medical Recent Developments
Table 135. LifeTech Corporation Information
Table 136. LifeTech Description and Major Businesses
Table 137. LifeTech Product Models, Descriptions and Specifications
Table 138. LifeTech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. LifeTech Recent Developments
Table 140. Gore Corporation Information
Table 141. Gore Description and Major Businesses
Table 142. Gore Product Models, Descriptions and Specifications
Table 143. Gore Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Gore Recent Developments
Table 145. Cordis Corporation Information
Table 146. Cordis Description and Major Businesses
Table 147. Cordis Product Models, Descriptions and Specifications
Table 148. Cordis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Cordis Recent Developments
Table 150. Acotec Scientific Holdings Corporation Information
Table 151. Acotec Scientific Holdings Description and Major Businesses
Table 152. Acotec Scientific Holdings Product Models, Descriptions and Specifications
Table 153. Acotec Scientific Holdings Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Acotec Scientific Holdings Recent Developments
Table 155. Zylox-Tonbridge Medical Technology Corporation Information
Table 156. Zylox-Tonbridge Medical Technology Description and Major Businesses
Table 157. Zylox-Tonbridge Medical Technology Product Models, Descriptions and Specifications
Table 158. Zylox-Tonbridge Medical Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Zylox-Tonbridge Medical Technology Recent Developments
Table 160. Key Raw Materials Distribution
Table 161. Raw Materials Key Suppliers
Table 162. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 163. Milestones in Production Technology Evolution
Table 164. Distributors List
Table 165. Market Trends and Market Evolution
Table 166. Market Drivers and Opportunities
Table 167. Market Challenges, Risks, and Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources


List of Figures
Figure 1. Aortic and Peripheral Vascular Interventional Devices Product Picture
Figure 2. Global Aortic and Peripheral Vascular Interventional Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Aorta Product Picture
Figure 4. Peripheral Blood Vessels Product Picture
Figure 5. Coronary Blood Vessels Product Picture
Figure 6. Cerebral Blood Vessels Product Picture
Figure 7. Global Aortic and Peripheral Vascular Interventional Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Aortic and Peripheral Vascular Interventional Devices Report Years Considered
Figure 12. Global Aortic and Peripheral Vascular Interventional Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2031) & (US$ Million)
Figure 14. Global Aortic and Peripheral Vascular Interventional Devices Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Aortic and Peripheral Vascular Interventional Devices Revenue Market Share by Region (2020-2031)
Figure 16. Global Aortic and Peripheral Vascular Interventional Devices Sales (2020-2031) & (K Units)
Figure 17. Global Aortic and Peripheral Vascular Interventional Devices Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Aortic and Peripheral Vascular Interventional Devices Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Aortic and Peripheral Vascular Interventional Devices Sales Volume Market Share in 2024
Figure 20. Global Aortic and Peripheral Vascular Interventional Devices Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Aorta Revenue Market Share by Manufacturer in 2024
Figure 23. Peripheral Blood Vessels Revenue Market Share by Manufacturer in 2024
Figure 24. Coronary Blood Vessels Revenue Market Share by Manufacturer in 2024
Figure 25. Cerebral Blood Vessels Revenue Market Share by Manufacturer in 2024
Figure 26. Global Aortic and Peripheral Vascular Interventional Devices Sales Market Share by Type (2020-2031)
Figure 27. Global Aortic and Peripheral Vascular Interventional Devices Revenue Market Share by Type (2020-2031)
Figure 28. Global Aortic and Peripheral Vascular Interventional Devices Sales Market Share by Application (2020-2031)
Figure 29. Global Aortic and Peripheral Vascular Interventional Devices Revenue Market Share by Application (2020-2031)
Figure 30. North America Aortic and Peripheral Vascular Interventional Devices Sales YoY (2020-2031) & (K Units)
Figure 31. North America Aortic and Peripheral Vascular Interventional Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 32. North America Top 5 Manufacturers Aortic and Peripheral Vascular Interventional Devices Sales Revenue (US$ Million) in 2024
Figure 33. North America Aortic and Peripheral Vascular Interventional Devices Sales Volume (K Units) by Type (2020- 2031)
Figure 34. North America Aortic and Peripheral Vascular Interventional Devices Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 35. North America Aortic and Peripheral Vascular Interventional Devices Sales Volume (K Units) by Application (2020-2031)
Figure 36. North America Aortic and Peripheral Vascular Interventional Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 37. US Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2031) & (US$ Million)
Figure 38. Canada Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2031) & (US$ Million)
Figure 39. Mexico Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2031) & (US$ Million)
Figure 40. Europe Aortic and Peripheral Vascular Interventional Devices Sales YoY (2020-2031) & (K Units)
Figure 41. Europe Aortic and Peripheral Vascular Interventional Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Europe Top 5 Manufacturers Aortic and Peripheral Vascular Interventional Devices Sales Revenue (US$ Million) in 2024
Figure 43. Europe Aortic and Peripheral Vascular Interventional Devices Sales Volume (K Units) by Type (2020-2031)
Figure 44. Europe Aortic and Peripheral Vascular Interventional Devices Sales Revenue (US$ Million) by Type (2020-2031)
Figure 45. Europe Aortic and Peripheral Vascular Interventional Devices Sales Volume (K Units) by Application (2020-2031)
Figure 46. Europe Aortic and Peripheral Vascular Interventional Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. Germany Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2031) & (US$ Million)
Figure 48. France Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2031) & (US$ Million)
Figure 49. U.K. Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2031) & (US$ Million)
Figure 50. Italy Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2031) & (US$ Million)
Figure 51. Russia Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Aortic and Peripheral Vascular Interventional Devices Sales YoY (2020-2031) & (K Units)
Figure 53. Asia-Pacific Aortic and Peripheral Vascular Interventional Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Top 8 Manufacturers Aortic and Peripheral Vascular Interventional Devices Sales Revenue (US$ Million) in 2024
Figure 55. Asia-Pacific Aortic and Peripheral Vascular Interventional Devices Sales Volume (K Units) by Type (2020- 2031)
Figure 56. Asia-Pacific Aortic and Peripheral Vascular Interventional Devices Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 57. Asia-Pacific Aortic and Peripheral Vascular Interventional Devices Sales Volume (K Units) by Application (2020-2031)
Figure 58. Asia-Pacific Aortic and Peripheral Vascular Interventional Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 59. Indonesia Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2031) & (US$ Million)
Figure 60. Japan Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2031) & (US$ Million)
Figure 61. South Korea Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2031) & (US$ Million)
Figure 62. China Taiwan Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2031) & (US$ Million)
Figure 63. India Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2031) & (US$ Million)
Figure 64. Central and South America Aortic and Peripheral Vascular Interventional Devices Sales YoY (2020-2031) & (K Units)
Figure 65. Central and South America Aortic and Peripheral Vascular Interventional Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Central and South America Top 5 Manufacturers Aortic and Peripheral Vascular Interventional Devices Sales Revenue (US$ Million) in 2024
Figure 67. Central and South America Aortic and Peripheral Vascular Interventional Devices Sales Volume (K Units) by Type (2021-2031)
Figure 68. Central and South America Aortic and Peripheral Vascular Interventional Devices Sales Revenue (US$ Million) by Type (2020-2031)
Figure 69. Central and South America Aortic and Peripheral Vascular Interventional Devices Sales Volume (K Units) by Application (2020-2031)
Figure 70. Central and South America Aortic and Peripheral Vascular Interventional Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 71. Brazil Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2025) & (US$ Million)
Figure 72. Argentina Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2025) & (US$ Million)
Figure 73. Middle East, and Africa Aortic and Peripheral Vascular Interventional Devices Sales YoY (2020-2031) & (K Units)
Figure 74. Middle East and Africa Aortic and Peripheral Vascular Interventional Devices Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Middle East and Africa Top 5 Manufacturers Aortic and Peripheral Vascular Interventional Devices Sales Revenue (US$ Million) in 2024
Figure 76. Middle East and Africa Aortic and Peripheral Vascular Interventional Devices Sales Volume (K Units) by Type (2021-2031)
Figure 77. South America Aortic and Peripheral Vascular Interventional Devices Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Middle East and Africa Aortic and Peripheral Vascular Interventional Devices Sales Volume (K Units) by Application (2020-2031)
Figure 79. Middle East and Africa Aortic and Peripheral Vascular Interventional Devices Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. GCC Countries Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2025) & (US$ Million)
Figure 81. Turkey Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2025) & (US$ Million)
Figure 82. Egypt Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2025) & (US$ Million)
Figure 83. South Africa Aortic and Peripheral Vascular Interventional Devices Revenue (2020-2025) & (US$ Million)
Figure 84. Aortic and Peripheral Vascular Interventional Devices Industry Chain Mapping
Figure 85. Regional Aortic and Peripheral Vascular Interventional Devices Manufacturing Base Distribution (%)
Figure 86. Global Aortic and Peripheral Vascular Interventional Devices Production Market Share by Region (2020-2031)
Figure 87. Aortic and Peripheral Vascular Interventional Devices Production Process
Figure 88. Regional Aortic and Peripheral Vascular Interventional Devices Production Cost Structure
Figure 89. Channels of Distribution (Direct Vs Distribution)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit